| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/26/2002 | WO2002068662A8 Plasmid originated from bifidobacterium, recombinant expression vector using the plasmid and transformation method |
| 09/26/2002 | WO2002062999A8 Proteins and nucleic acids encoding same |
| 09/26/2002 | WO2002062957A3 Ter sites and ter binding proteins |
| 09/26/2002 | WO2002057406A3 Dna sequencing of abc transporter or multi drug resistant protein for better environment stress tolerant crops |
| 09/26/2002 | WO2002055665A3 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 09/26/2002 | WO2002055659A3 Antisense modulation of integrin beta 4 binding protein expression |
| 09/26/2002 | WO2002053581A3 Spliceosome mediated rna trans-splicing |
| 09/26/2002 | WO2002046214A3 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/26/2002 | WO2002045492A8 Transgenic mice containing polycystin-related gene disruptions |
| 09/26/2002 | WO2002042767A3 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium |
| 09/26/2002 | WO2002040709A3 Genetic test for the identification of carriers of complex vertebral malformations in cattle |
| 09/26/2002 | WO2002040501A3 Membrane scaffold proteins |
| 09/26/2002 | WO2002038787A3 Secondary liquefaction of starch in ethanol production |
| 09/26/2002 | WO2002038609A3 Apolipoprotein conjugates |
| 09/26/2002 | WO2002037938A3 Method and device for selectively targeting cells within a three -dimensional specimen |
| 09/26/2002 | WO2002036786A3 Method of selecting plant promoters to control transgene expression |
| 09/26/2002 | WO2002036752A3 Method of producing non-bovine chymosin and use thereof |
| 09/26/2002 | WO2002036167A8 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 09/26/2002 | WO2002032945A3 Haemophilus influenzae basb206 gene and protein |
| 09/26/2002 | WO2002032461A3 Protein c or activated protein c-like molecules |
| 09/26/2002 | WO2002031155A3 Gene cluster for ramoplanin biosynthesis |
| 09/26/2002 | WO2002029084A3 Industrial-scale serum-free production of recombinant factor vii in mammalian cells |
| 09/26/2002 | WO2002029080A3 Fermentation process for the preparation of l-amino acids using strains of the family enterobacteriaceae |
| 09/26/2002 | WO2002026996A3 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 09/26/2002 | WO2002026954A3 Truncated phosphodiesterase-7 polypeptides |
| 09/26/2002 | WO2002022685A3 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 09/26/2002 | WO2002019813A3 Method of obtaining a non-human mammal susceptible to adenovirus-mediated gene delivery |
| 09/26/2002 | WO2002016611A3 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 09/26/2002 | WO2002016396A9 Mammalian rh type b glycoprotein ion transporter |
| 09/26/2002 | WO2002015918A3 Method and compositions for promoting osteogenesis |
| 09/26/2002 | WO2002015675A8 Genes for modifying plant traits iv |
| 09/26/2002 | WO2002004519A3 Murine cytokine receptor |
| 09/26/2002 | WO2002002626A3 Novel secreted proteins |
| 09/26/2002 | WO2002000905A3 Plant regulatory sequences for selective control of gene expression |
| 09/26/2002 | WO2002000710A3 B7-like molecules and uses thereof |
| 09/26/2002 | WO2002000693A3 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 09/26/2002 | WO2001098332A3 Secreted redox proteins |
| 09/26/2002 | WO2001095711A3 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 09/26/2002 | WO2001094600A3 Promoters for regulated gene expression |
| 09/26/2002 | WO2001094418A3 Leader peptides for enhancing secretion of recombinant protein from a host cell |
| 09/26/2002 | WO2001092488A3 Regulation of human plc delta-1 |
| 09/26/2002 | WO2001092487A3 Modified xylanases exhibiting increased thermophilicity and alkalophilicity |
| 09/26/2002 | WO2001092465A8 Maize glutamine synthetase gene promoter |
| 09/26/2002 | WO2001090159B1 Compositions and methods for delivery of a molecule into a cell |
| 09/26/2002 | WO2001090143A3 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 09/26/2002 | WO2001088109A8 Model for neurodegenerative disease |
| 09/26/2002 | WO2001083775A3 Proteases |
| 09/26/2002 | WO2001073002A3 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 09/26/2002 | WO2001070969A3 Regulation of human latrophilin-like g protein-coupled receptor |
| 09/26/2002 | WO2001061019A3 A dominant selectable marker for gene transformation and disruption in yeasts |
| 09/26/2002 | WO2001047953A3 Antibodies against plasma cells |
| 09/26/2002 | WO2001036683A3 Method for rapid and accurate identification of microorganisms |
| 09/26/2002 | WO2001032156A3 Methods for treating fibroproliferative diseases |
| 09/26/2002 | WO2001027158A3 Olfactory receptor sequences |
| 09/26/2002 | WO2001025401A9 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins |
| 09/26/2002 | WO2001023421A9 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 09/26/2002 | WO2001020012A9 Enhanced plant cell transformation by addition of host genes involved in t-dna integration |
| 09/26/2002 | WO2001019977A9 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 09/26/2002 | WO2001019861A9 Apo-2 receptor antibodies |
| 09/26/2002 | WO2001019845A9 Cacna1g polynucleotide, polypeptide and methods of use therefor |
| 09/26/2002 | WO2001019393A9 Delivering to eucaryotic cells bacterial proteins that are secreted via type iii secretion systems |
| 09/26/2002 | WO2001018183A9 Methods and compositions for production of floral scent compounds |
| 09/26/2002 | WO2001011054A9 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STAPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) |
| 09/26/2002 | WO2000034495A3 A method of genetically modifying very primitive quiescent human hematopoietic stem cells |
| 09/26/2002 | WO2000027868A9 Connective tissue growth factor (ctgf) and methods of use |
| 09/26/2002 | US20020138880 Isolating a cation transport gene (magnesium transport gene) comprises selecting from suitable vectors expressing plant or animal cDNAs in yeast for clones that confer a high tolerance to aluminum |
| 09/26/2002 | US20020138879 Agrobacterium-transformed sorghum plant comprises fewer than 5 copies of a nucleic acid of interest flanked by atleast on T-DNA border sequence incorporated in its genome |
| 09/26/2002 | US20020138878 Transgenic plants comprise ligninase and cellulase genes from microbes operably linked to a DNA encoding a signal peptide which targets the fusion polypeptide prodcued therefrom to an organelle of the plant |
| 09/26/2002 | US20020138877 Rad3 orthologues and uses thereof |
| 09/26/2002 | US20020138876 Transformed plant cells and plants regenerated from these cells, which exhibit an increase or reduced activity of starch synthases; genetic engineering |
| 09/26/2002 | US20020138875 Expression of fructose 1,6 bisphosphate aldolase (FDA) in transgenic plants to increase or improve plant growth and development, yield, vigor, stress tolerance, carbon allocation and storage and distribution of starch |
| 09/26/2002 | US20020138874 Elongase genes and uses thereof |
| 09/26/2002 | US20020138873 Multiple component RNA vector system for expression of foreign sequences |
| 09/26/2002 | US20020138872 Transgenic plants; enhanced defense mechanisms to combat plant diseases; disease resistant plants |
| 09/26/2002 | US20020138870 Methods for simultaneous control of lignin content and composition, and cellulose content in plants |
| 09/26/2002 | US20020138869 Plant cell death system |
| 09/26/2002 | US20020138868 Modulating endoreduplication in a plant or part thereof which comprises modifying expression or activity of the transciption factor E2Fa; use of Arabidopsis thaliana nucleotide sequences |
| 09/26/2002 | US20020138867 Geminivirus resistant transgenic plants |
| 09/26/2002 | US20020138865 In vitro transfection, storage and transfer of male germ cells for generation of transgenic species & genetic therapies |
| 09/26/2002 | US20020138864 Electroporating a foreign gene into avian primordial germ cells after addition of dimethyl sulfoxide to culture medium containing the cells |
| 09/26/2002 | US20020138863 Transgenic knockout mouse with homozygous disruption in its endogenous endothelial receptor (FcRn) gene; animal model for autoimmune disorders; FcRn selectively protects antibodies of immunoglobulin G isotype from catabolism |
| 09/26/2002 | US20020138862 Mice show an increased insulin sensitivity, and resistance to weight gain compared to wild-type mice on same diet; screening for enzyme inhibitors; antiobesity, antidiabetic agents |
| 09/26/2002 | US20020138859 Nucleic acid sequences; use of such enzymes to produce taxanes |
| 09/26/2002 | US20020138857 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 09/26/2002 | US20020138855 Non-invasive evaluation of physiological response in a mammal |
| 09/26/2002 | US20020138208 Method for analyzing mass spectra |
| 09/26/2002 | US20020138207 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 09/26/2002 | US20020138049 Microneedle devices and methods of manufacture and use thereof |
| 09/26/2002 | US20020137921 Oligonucleotides having chiral phosphorus linkages |
| 09/26/2002 | US20020137920 Magnetic pigment |
| 09/26/2002 | US20020137918 Immnunoglobulin light chain binding protein for use in immunoaffinity chromatography |
| 09/26/2002 | US20020137916 Sphingosine 1-phosphate receptor gene, sppr |
| 09/26/2002 | US20020137915 Conformational and topological protein regulation |
| 09/26/2002 | US20020137914 Novel human dectin proteins and polynucleotides encoding the same |
| 09/26/2002 | US20020137913 Novel human kinases and polynucleotides encoding the same |
| 09/26/2002 | US20020137912 Polynucleotide with the activity of carbon starvation protein A (cstA); fermentative preparation of L-amino acids, such as L-lysine |
| 09/26/2002 | US20020137911 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 09/26/2002 | US20020137908 Novel guanosine triphosphate (GTP) binding protein-coupled receptor protein, BG3 |
| 09/26/2002 | US20020137907 Novel compounds |
| 09/26/2002 | US20020137894 Megakaryocyte stimulating factors |